Annual report pursuant to Section 13 and 15(d)

Earnings (Loss) Per Share (EPS) Additional Information (Details)

v3.19.3.a.u2
Earnings (Loss) Per Share (EPS) Additional Information (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
$ / shares
Mar. 31, 2019
shares
Dec. 31, 2019
$ / shares
shares
Dec. 31, 2018
shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Exercise price (in dollars per share) | $ / shares $ 23      
Initial exercise price (in dollars per share) | $ / shares     $ 48.85  
Preferred stock, convertible into common stock (in shares) | shares   500,000   500,000
Preferred stock, conversion ratio   47.6190    
Predecessor preferred stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Common stock after conversion (in shares) | shares   1,587,300 0 1,587,300